Sinopharm Group Co. Ltd - Asset Resilience Ratio

Latest as of June 2025: 0.00%

Sinopharm Group Co. Ltd (X2S) has an Asset Resilience Ratio of 0.00% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Sinopharm Group Co. Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

€127.00K
≈ $148.48K USD Cash + Short-term Investments

Total Assets

€420.33 Billion
≈ $491.41 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2024)

This chart shows how Sinopharm Group Co. Ltd's Asset Resilience Ratio has changed over time. See Sinopharm Group Co. Ltd (X2S) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Sinopharm Group Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sinopharm Group Co. Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €127.00K 0.0%
Total Liquid Assets €127.00K 0.00%

Asset Resilience Insights

  • Limited Liquidity: Sinopharm Group Co. Ltd maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Sinopharm Group Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Sinopharm Group Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.44%
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
Medical Distribution 5.56%

Annual Asset Resilience Ratio for Sinopharm Group Co. Ltd (2013–2024)

The table below shows the annual Asset Resilience Ratio data for Sinopharm Group Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.00% €158.00K
≈ $184.72K
€392.83 Billion
≈ $459.26 Billion
0.00pp
2023-12-31 0.00% €547.00K
≈ $639.50K
€383.39 Billion
≈ $448.23 Billion
+0.00pp
2022-12-31 0.00% €498.00K
≈ $582.21K
€364.78 Billion
≈ $426.46 Billion
0.00pp
2021-12-31 0.00% €11.75 Million
≈ $13.74 Million
€335.41 Billion
≈ $392.13 Billion
-0.01pp
2020-12-31 0.01% €39.14 Million
≈ $45.76 Million
€311.24 Billion
≈ $363.87 Billion
+0.01pp
2019-12-31 0.00% €156.00K
≈ $182.38K
€269.89 Billion
≈ $315.53 Billion
-0.02pp
2018-12-31 0.02% €41.20 Million
≈ $48.17 Million
€235.77 Billion
≈ $275.64 Billion
-0.09pp
2017-12-31 0.10% €175.61 Million
≈ $205.31 Million
€169.54 Billion
≈ $198.21 Billion
+0.10pp
2016-12-31 0.00% €5.47 Million
≈ $6.39 Million
€157.71 Billion
≈ $184.38 Billion
-0.88pp
2015-12-31 0.88% €1.23 Billion
≈ $1.44 Billion
€139.43 Billion
≈ $163.01 Billion
-0.04pp
2014-12-31 0.93% €1.19 Billion
≈ $1.39 Billion
€128.66 Billion
≈ $150.41 Billion
+0.10pp
2013-12-31 0.83% €874.07 Million
≈ $1.02 Billion
€105.45 Billion
≈ $123.29 Billion
--
pp = percentage points

About Sinopharm Group Co. Ltd

F:X2S Germany Medical Distribution
Market Cap
$3.15 Billion
€2.69 Billion EUR
Market Cap Rank
#4790 Global
#801 in Germany
Share Price
€2.01
Change (1 day)
-0.94%
52-Week Range
€1.98 - €2.37
All Time High
€2.71
About

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical … Read more